AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
BreastCarcinoma, Ductal, BreastBreast DiseasesBreast FeedingBreast Neoplasms, MaleReceptors, EstrogenMammographyFibrocystic Breast DiseaseCell Line, TumorBreast ImplantsReceptor, erbB-2Breast Self-ExaminationReceptors, ProgesteroneTamoxifenGene Expression Regulation, NeoplasticCarcinoma, Intraductal, NoninfiltratingMastectomyPrognosisTumor Markers, BiologicalCarcinoma, LobularNeoplasm InvasivenessUltrasonography, MammaryNeoplasm MetastasisRisk FactorsGenes, BRCA1Antineoplastic Agents, HormonalCase-Control StudiesLymphatic MetastasisNeoplasm StagingImmunohistochemistryPostmenopauseMastectomy, SegmentalMilk, HumanMammaplastyTumor Cells, CulturedBreast CystCarcinomaAntineoplastic AgentsNeoplasm ProteinsChemotherapy, AdjuvantMCF-7 CellsMammary Glands, HumanFibroadenomaEstrogen Receptor alphaNipplesEstrogensPremenopauseMammary Neoplasms, ExperimentalBreast ImplantationBRCA2 ProteinMenopauseBRCA1 ProteinAxillaTime FactorsCell ProliferationGenes, BRCA2Neoplasms, Hormone-DependentGenetic Predisposition to DiseaseTriple Negative Breast NeoplasmsInflammatory Breast NeoplasmsGenes, erbB-2Carcinoma, DuctalTreatment OutcomeGene Expression ProfilingAromatase InhibitorsEstrogen AntagonistsFollow-Up StudiesCarcinoma in SituNeoplasm Recurrence, LocalDisease-Free SurvivalSurvival AnalysisMass ScreeningIncidenceAge FactorsAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesMice, NudeRetrospective StudiesDrug Resistance, NeoplasmRNA, MessengerProspective StudiesRiskSensitivity and SpecificityRisk AssessmentReverse Transcriptase Polymerase Chain ReactionEstradiolSignal TransductionBiopsy, NeedleMastectomy, Modified RadicalUnited StatesReproducibility of ResultsSurvival RateDNA, NeoplasmOvarian NeoplasmsOdds RatioSelective Estrogen Receptor ModulatorsApoptosisDisease ProgressionNeoadjuvant TherapyMultivariate Analysis